Supplementary Figure 3 from Seribantumab, an Anti-ERBB3 Antibody, Delays the Onset of Resistance and Restores Sensitivity to Letrozole in an Estrogen Receptor–Positive Breast Cancer Model
crossref（2023）
摘要
Pharmacodynamic analyses of HRG and ERBB3 expression in tumors harvested post-treatment
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要